Efficacy study of single-agent gemcitabine versus gemcitabine plus carboplatin in untreated elderly patients with stage IIIb/IV non-small-cell lung cancer

National Medical Journal of China

Volumn 90, Issue 2, 2010, Pages 100-102

  Lou, Guang Yuan ^a   Li, Tie ^a   Gu, Cui Ping ^a   Hong, Dan ^a   Zhang, Yi Ping ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Carboplatin; Carcinoma, non small cell lung; Elderly; Gemcitabine

Indexed keywords

CARBOPLATIN; GEMCITABINE; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE;

ADVERSE OUTCOME; AGED; APPETITE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; THROMBOCYTOPENIA; TREATMENT RESPONSE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; LUNG TUMOR; MALE; PATHOLOGY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING;

EID: 84871427550     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2010.02.009     Document Type: Article

References (10)

1. Lsakin J J, Sandler A B. First-line treatment for advanced non-small-cell lung cancer. Oncology (Williston Park), 2005, 19: 1671-1676.
2. Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced nonsmall cell lung Cancer: The Multicenter Italian Lung Cancer in Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst, 2003, 95: 362-372.
3. Langer C J, Manola J, Bernardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst, 2002, 94: 173-181.
4. Costa G J, Fernandes A L, Pereira J R, et al. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer, 2006, 53: 171-176.
5. Belani C P, Fossella F. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced non-small-cell lung carcinoma (TAX326). Cancer, 2005, 104: 2766-2774.
6. Bianco V, Rozzi A, Tonini G, et al. Gemcitabine as single agent chemotheraphy in elderly patients with stages III-IV non-small cell lung cancer(NSCLC): a phase II study. Anticancer Res, 2002, 22: 3053-3056.
7. Martoni A, Di Fabio F, Guaraldi M, et al. Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage III B/IV non-small-cell lung cancer. Am J Clin Oncol, 2001, 24: 614-617.
8. 2004, 23: 24-26.
9. 2006, 25: 354-355.
10. Kortsik C, Albrecht P, Elmer A. Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study. Lung Cancer, 2003, 40: 85-90.